Immune tolerance induction (ITI) according to the Bonn protocol in haemophilia A patients with inhibitors using a plasma-derived VWF-containing factor VIII concentrate: two paediatric case reports

被引：0
|
作者：
Lohse, J. [1 ]
Gehrisch, S. [1 ]
Escuriola-Ettingshausen, C. [2 ]
Kreuz, W. [2 ]
Knoefler, R. [1 ]
机构：
[1] Univ Hosp Dresden, Dresden, Germany
[2] Johann Wolfgang Goethe Univ Hosp, Frankfurt, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1073 / 1074
页数：2
相关论文
共 33 条
  • [21] Immune tolerance with a high purity plasma derived factor VIII containing von Willebrand factor in haemophilia A patients with high responding inhibitors.
    Polack, B
    Beurrier, P
    Rothschild, C
    Orsini, F
    Faradji, A
    Liennhard, A
    Fressinaud, E
    Goudemand, J
    BLOOD, 2004, 104 (11) : 846A - 846A
  • [22] IMPACT OF FACTOR VIII GENE (F8) MUTATION ON IMMUNE TOLERANCE INDUCTION (ITI) OUTCOMES IN HAEMOPHILIA A PATIENTS WITH INHIBITORS IN THE OBSITI STUDY
    Pavlova, A.
    Escuriola-Ettingshausen, C.
    Oldenburg, J.
    HAEMOPHILIA, 2020, 26 : 54 - 54
  • [23] Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE®), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: A multicentre, retrospective study
    Robertson, Jeremy D.
    Higgins, Pauline
    Price, Jamie
    Dunkley, Scott
    Barrese, Giulio
    Curtin, Julie
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1046 - 1051
  • [24] Allergic reaction in a cohort of haemophilia A patients using plasma-derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII
    Montalvao, S. A. L.
    Tucunduva, A. C.
    Siqueira, L. H.
    Sambo, A. L. A.
    Medina, S. S.
    Ozelo, M. C.
    HAEMOPHILIA, 2015, 21 (04) : E281 - E285
  • [25] Successful Low-Dose Immune Tolerance Induction Regimen Using Multiple Plasma-Derived Factor VIII Concentrates
    Colella, M.
    Montalvao, S.
    Sambo, A.
    De Paula, E.
    Ozelo, M.
    HAEMOPHILIA, 2012, 18 : 92 - 92
  • [26] Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate
    Gringeri, A
    Monzini, M
    Tagariello, G
    Scaraggi, FA
    Mannucci, PM
    HAEMOPHILIA, 2006, 12 (02) : 128 - 132
  • [27] Immune Tolerance Induction (ITI) in Paediatric and Adult Patients with Haemophilia a (HA) and High-Titre (HT) Factor VIII (FVIII) Inhibitor - Real Life Data
    Letowska, Magdalena Katarzyna
    Zawilska, Krystyna
    Klukowska, Anna
    Chojnowski, Krzysztof
    Zdziarska, Joanna
    Stefanska-Windyga, Ewa
    Windyga, Jerzy
    BLOOD, 2019, 134
  • [28] Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response
    Gringeri, A.
    Musso, R.
    Mazzucconi, M. G.
    Piseddu, G.
    Schiavoni, M.
    Pignoloni, P.
    Mannucci, P. M.
    HAEMOPHILIA, 2007, 13 (04) : 373 - 379
  • [29] Immune Tolerance Induction (ITI) With Factor IX and Combined Immunosuppressive Therapy in two Patients With Severe Haemophilia B, Longstanding Inhibitors and Previous Allergic Reactions
    Holstein, K.
    Voigtlaender, M.
    Dicke, C.
    Langer, F.
    HAEMOPHILIA, 2017, 23 : 93 - 93
  • [30] The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile
    Greninger, D. A.
    Saint-Remy, J. M.
    Jacquemin, M.
    Benhida, A.
    Dimichele, D. M.
    HAEMOPHILIA, 2008, 14 (02) : 295 - 302
1234